Semi-Supervised Approach to Monitoring Clinical Depressive Symptoms in Social Media

With the rise of social media, millions of people are routinely expressing their moods, feelings, and daily struggles with mental health issues on social media platforms like Twitter. Unlike traditional observational cohort studies conducted through questionnaires and self-reported surveys, we explore the reliable detection of clinical depression from tweets obtained unobtrusively. Based on the analysis of tweets crawled from users with self-reported depressive symptoms in their Twitter profiles, we demonstrate the potential for detecting clinical depression symptoms which emulate the PHQ-9 questionnaire clinicians use today. Our study uses a semi-supervised statistical model to evaluate how the duration of these symptoms and their expression on Twitter (in terms of word usage patterns and topical preferences) align with the medical findings reported via the PHQ-9. Our proactive and automatic screening tool is able to identify clinical depressive symptoms with an accuracy of 68% and precision of 72%.Comment: 8 pages, Advances in Social Networks Analysis and Mining (ASONAM), 2017 IEEE/ACM International Conferenc

Depression and Self-Harm Risk Assessment in Online Forums

Users suffering from mental health conditions often turn to online resources for support, including specialized online support communities or general communities such as Twitter and Reddit. In this work, we present a neural framework for supporting and studying users in both types of communities. We propose methods for identifying posts in support communities that may indicate a risk of self-harm, and demonstrate that our approach outperforms strong previously proposed methods for identifying such posts. Self-harm is closely related to depression, which makes identifying depressed users on general forums a crucial related task. We introduce a large-scale general forum dataset ("RSDD") consisting of users with self-reported depression diagnoses matched with control users. We show how our method can be applied to effectively identify depressed users from their use of language alone. We demonstrate that our method outperforms strong baselines on this general forum dataset.Comment: Expanded version of EMNLP17 paper. Added sections 6.1, 6.2, 6.4, FastText baseline, and CNN-

Using Machine Learning and Natural Language Processing to Review and Classify the Medical Literature on Cancer Susceptibility Genes

PURPOSE: The medical literature relevant to germline genetics is growing exponentially. Clinicians need tools monitoring and prioritizing the literature to understand the clinical implications of the pathogenic genetic variants. We developed and evaluated two machine learning models to classify abstracts as relevant to the penetrance (risk of cancer for germline mutation carriers) or prevalence of germline genetic mutations. METHODS: We conducted literature searches in PubMed and retrieved paper titles and abstracts to create an annotated dataset for training and evaluating the two machine learning classification models. Our first model is a support vector machine (SVM) which learns a linear decision rule based on the bag-of-ngrams representation of each title and abstract. Our second model is a convolutional neural network (CNN) which learns a complex nonlinear decision rule based on the raw title and abstract. We evaluated the performance of the two models on the classification of papers as relevant to penetrance or prevalence. RESULTS: For penetrance classification, we annotated 3740 paper titles and abstracts and used 60% for training the model, 20% for tuning the model, and 20% for evaluating the model. The SVM model achieves 89.53% accuracy (percentage of papers that were correctly classified) while the CNN model achieves 88.95 % accuracy. For prevalence classification, we annotated 3753 paper titles and abstracts. The SVM model achieves 89.14% accuracy while the CNN model achieves 89.13 % accuracy. CONCLUSION: Our models achieve high accuracy in classifying abstracts as relevant to penetrance or prevalence. By facilitating literature review, this tool could help clinicians and researchers keep abreast of the burgeoning knowledge of gene-cancer associations and keep the knowledge bases for clinical decision support tools up to date